A new European Commission report reinforces the role of biosimilars in improving access and supporting the sustainability of healthcare systems across Europe.
📄 Capacity building to support the uptake of biosimilars in a multistakeholder approach
👉 Key insights:
• Estimated savings exceeding €13 billion across Europe
• Increased availability and access to biological therapies
• Persistent barriers linked to policy design, implementation capacity and stakeholder acceptance
The study also includes contributions from:
Julian Perelman, Joana Alves, Carolina Santos, Henrique Vasconcelos and Pedro Pita Barros
🔗 Access the full report:
https://biosimilars.goeg.at/en/publications
The findings are aligned with previous evidence on the topic, particularly regarding the gap between policy design and implementation.